YOLFTbeta
68

AVE Science & Technology Co Ltd

688067 · SHG · Healthcare / Medical Instruments & Supplies

20.52CNY-0.49 (-2.33%)

Price History

Full chart

Market Stats

Previous Close21.01
Open20.95
Day Range20.43 – 21.21
52-Week Range17.63 – 29.64
Volume956.66K
Market Cap1.67B
P/E (TTM)51.08
Forward P/E0.00
EPS0.48
Dividend Yield0.63%
Beta0.46
50-Day Avg22.66
200-Day Avg24.97

About

AVE Science&Technology CO.,LTD researches, develops, manufactures, markets, and services medical devices, biological reagents, remote medical diagnosis network, computer software, automatic control devices, and medical auxiliary equipment. It provides urine formed elements analyzers and related reagents, automatic urine analyzers, multi-function microscopy analyzers, semi-automatic biochemical analyzers, feces analyzers, and vaginal secretion analyzers; and reagents and consumables comprising reagent packs, test strips, urine analyzer cleansers, urine sample collectors, and urine formed elements analyzer quality control products. It serves customers in China, Europe, the United States, Asia, Africa, and internationally. AVE Science&Technology CO.,LTD was incorporated in 2000 and is headquartered in Changsha, China.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. Jianwen Ding
  • Employees536
  • HeadquartersNo. 26, Fuling Road, Changsha, China, 410208, China
  • Websitehttps://www.c-ave.com

Leadership

  • Mr. Jianwen DingGM & Chairman · b. 1957
  • Mr. Kunxiang LongCFO & Accounting Supervisor · b. 1974
  • Mr. Changqing LinDeputy GM & Director · b. 1972
  • Mr. Fengliang ZhouDeputy GM & Director · b. 1965
  • Mr. Hui Jie YuanSecretary to the Board · b. 1992

Financials

Income Statement

Currency: CNY2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue68.41M81.95M79.65M92.50M117.05M135.63M150.54M189.98M180.20M210.67M196.77M200.31M203.32M230.03M
Growth (%)-+19.80%-2.81%+16.13%+26.54%+15.87%+10.99%+26.20%-5.15%+16.91%-6.60%+1.79%+1.50%+13.14%
Cost of Revenue15.10M20.74M22.71M29.40M39.32M46.24M53.05M62.83M74.39M86.85M91.17M87.50M82.56M86.86M
Gross Profit53.31M61.22M56.95M63.10M77.73M89.40M97.49M127.15M105.81M123.82M105.61M112.81M120.76M230.03M
Gross Margin77.93%74.70%71.49%68.22%66.40%65.91%64.76%66.93%58.72%58.77%53.67%56.32%59.39%100.00%
Operating Expense37.86M48.72M46.78M48.17M55.70M58.59M67.30M69.66M71.36M89.61M87.10M90.43M97.15M199.89M
Operating Income15.44M12.49M10.16M14.93M22.03M30.81M30.19M57.49M34.45M34.20M18.51M22.38M23.61M30.13M
Operating Margin22.58%15.25%12.76%16.14%18.82%22.71%20.05%30.26%19.12%16.24%9.41%11.17%11.61%13.10%
EBITDA16.33M23.22M21.18M29.42M36.61M34.85M34.68M61.89M39.22M40.68M27.26M33.23M34.82M41.32M
EBITDA Margin23.87%28.33%26.59%31.80%31.27%25.69%23.04%32.57%21.76%19.31%13.85%16.59%17.13%17.96%
Net Income19.56M19.91M17.13M24.55M30.29M27.38M27.28M50.52M30.10M31.28M17.97M21.53M22.84M28.94M
Net Income Margin28.60%24.30%21.51%26.54%25.88%20.18%18.12%26.59%16.70%14.85%9.13%10.75%11.23%12.58%
R&D-9.34M---12.64M19.16M20.48M22.62M31.20M33.08M27.72M25.38M27.35M
R&D as % of Total Revenue-11.40%---9.32%12.73%10.78%12.55%14.81%16.81%13.84%12.48%11.89%
Interest Expense-----25.95K14.03K13.63K23.34K17.19K30.24K25.40K-198.25K
Interest Expense % of Total Revenue-----0.02%0.01%0.01%0.01%0.01%0.02%0.01%-0.09%

Balance Sheet

Currency: CNY2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets121.83M141.16M160.93M166.53M211.37M224.08M257.67M297.44M296.57M547.61M549.65M556.69M561.00M580.12M
Total Liabilities18.72M20.01M22.65M18.99M33.54M34.13M40.40M44.94M59.85M70.03M74.53M66.85M65.15M65.77M
Total Equity103.11M121.15M138.28M147.53M177.84M189.95M217.27M252.51M236.72M477.58M475.12M489.84M495.85M514.36M
Cash34.05M37.97M31.98M31.83M47.84M24.53M42.97M33.48M24.82M228.28M149.88M82.80M53.72M47.70M
Total Debt500.00K-------------
Net Debt-33.55M-37.97M-31.98M-31.83M-47.84M-24.53M-42.97M-33.48M-24.82M-228.28M-149.88M-82.80M-53.72M-

Cash Flow

Currency: CNY2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow13.53M14.87M23.43M21.35M31.19M24.76M40.36M62.10M46.93M47.19M29.74M22.73M22.41M41.54M
Investing Cash Flow-45.50M-10.07M-29.42M-6.20M-19.11M-36.35M-25.97M-53.95M-6.03M-48.05M-87.71M-83.00M-34.82M-
Financing Cash Flow37.50M469.48K20.00K-15.30M-3.60M-10.20M0-15.44M-47.36M209.91M-20.40M-6.80M-16.83M-
Capital Expenditure17.56M7.44M38.72M17.82M22.46M48.06M17.37M24.49M11.80M20.52M21.20M4.50M3.75M3.21M
Free Cash Flow-4.03M7.43M-15.29M3.53M8.73M-23.30M22.99M37.61M35.13M26.67M8.54M18.23M18.66M38.32M
Dividends Paid12.00M10.52K-15.30M-10.20M-15.30M45.90M-20.40M6.80M6.80M10.36M
FCF to OCF-29.78%49.96%-65.25%16.53%27.99%-94.07%56.96%60.56%74.85%56.52%28.70%80.21%83.26%92.27%
Dividend Paid to FCF-297.74%0.14%-433.63%--43.78%-40.68%130.66%-239.01%37.30%36.44%27.03%

Earnings

Report DateSep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023
EPS Estimate-------
EPS Actual0.220.060.090.090.18-0.090.03
Surprise-------
Timing-------

Key Statistics & Ratios

Market Cap1.67B
Enterprise Value1.47B
Trailing P/E51.08
Forward P/E0.00
Price / Sales7.46
Price / Book3.11
EPS0.48
Book Value7.81
Revenue (TTM)223.38M
Gross Profit (TTM)138.33M
EBITDA38.41M
Profit Margin14.55%
Operating Margin14.83%
Return on Equity6.32%
Return on Assets2.77%
Shares Outstanding68.00M
Shares Float33.14M
Beta0.46
Dividend Yield0.63%
Dividend Rate0.15
Payout Ratio32.08%

Dividends

20261×
0.10Jul 15, 2026
20252×
0.05Dec 8, 20250.10Jul 14, 2025
20241×
0.10Jul 4, 2024
20231×
0.10Jul 14, 2023
20221×
0.30Jul 18, 2022